GTX INC (84) | Human Resources (22)

Browse by Subcategory

Recent Contracts

2019 Incentive Award Plan of the Registrant effective June 7, 2019 (the 2019 Plan) (Filed With SEC on March 10, 2022)
Employment Agreement dated May 17, 2021 between Oncternal Therapeutics, Inc. and Salim Yazji, M.D (Filed With SEC on August 5, 2021)
Employment Transition Agreement between Frank Hsu, M.D. and Registrant, dated February 24, 2021 (Filed With SEC on May 6, 2021)
Non-Employee Director Compensation Policy, as amended and restated, effective March 18, 2021 (Filed With SEC on May 6, 2021)
Consulting Agreement dated September 20, 2019 between Robert J. Wills. Ph.D. and Oncternal Therapeutics, Inc (Filed With SEC on March 16, 2020)
Employment Agreement dated April 12, 2021 between Oncternal Therapeutics, Inc. and Chase Leavitt (Filed With SEC on August 5, 2021)
Amended and Restated Employment Agreement dated January 6, 2021 between Oncternal Therapeutics, Inc. and Raj Krishnan, Ph.D (Filed With SEC on August 5, 2021)
Amendment No. 1 to the Oncternal Therapeutics, Inc. 2021 Employment Inducement Incentive Award Plan (Filed With SEC on May 28, 2021)
Oncternal Therapeutics, Inc. 2021 Employment Inducement Incentive Award Plan and form of stock option agreement thereunder (Filed With SEC on February 17, 2021)
Amended Oncternal Therapeutics, Inc. Annual Incentive Plan (Filed With SEC on November 8, 2019)
Employment Agreement dated September 5, 2019 between Oncternal Therapeutics, Inc. and Hazel M. Aker (Filed With SEC on November 8, 2019)
Employment Agreement dated September 5, 2019 between Oncternal Therapeutics, Inc. and Richard G. Vincent (Filed With SEC on November 8, 2019)
Employment Agreement dated September 12, 2019 between Oncternal Therapeutics, Inc. and James B. Breitmeyer, M.D (Filed With SEC on November 8, 2019)
Employment Agreement dated September 9, 2019 between Oncternal Therapeutics, Inc. and Igor P. Bilinsky, Ph.D (Filed With SEC on November 8, 2019)
Employment Agreement dated September 5, 2019 between Oncternal Therapeutics, Inc. and Gunnar F. Kaufmann, Ph.D (Filed With SEC on November 8, 2019)
Employment Agreement dated August 26, 2019 between Oncternal Therapeutics, Inc. and Frank Hsu, M.D (Filed With SEC on November 8, 2019)
Form of Stock Option Agreement under the Oncternal Therapeutics, Inc. 2015 Equity Incentive Plan, as amended (Filed With SEC on April 8, 2019)
Consulting Agreement dated April 3, 2017, between Oncternal Therapeutics, Inc. and Richard G. Vincent (Filed With SEC on April 8, 2019)
Employment Letter dated January 1, 2019, between Oncternal Therapeutics, Inc. and Richard G. Vincent (Filed With SEC on April 8, 2019)
Employment Letter dated May 31, 2017, between Oncternal Therapeutics, Inc. and James B. Breitmeyer, M.D., Ph.D (Filed With SEC on April 8, 2019)
Form of Early Exercise Stock Option Agreement under the Oncternal Therapeutics, Inc. 2015 Equity Incentive Plan, as amended (Filed With SEC on April 8, 2019)
Oncternal Therapeutics, Inc. 2015 Equity Incentive Plan, as amended (Filed With SEC on April 8, 2019)